tetano
Editor, Senior Moderator
Case Rep Crit Care
. 2022 Oct 11;2022:8807957.
doi: 10.1155/2022/8807957. eCollection 2022.
Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
Bhargavi Donepudi[SUP] 1 [/SUP], Shikhar Agarwal[SUP] 2 [/SUP], Lokendra Thakur[SUP] 1 [/SUP]
Affiliations
Abstract
Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.
. 2022 Oct 11;2022:8807957.
doi: 10.1155/2022/8807957. eCollection 2022.
Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
Bhargavi Donepudi[SUP] 1 [/SUP], Shikhar Agarwal[SUP] 2 [/SUP], Lokendra Thakur[SUP] 1 [/SUP]
Affiliations
- PMID: 36267193
- PMCID: PMC9578912
- DOI: 10.1155/2022/8807957
Abstract
Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.